Story at-a-glance In 2019, Bill Gates invested $55 million in BioNtech, which developed the COVID-19 shot for Pfizer; it’s now worth $550 million Gates sold some of the stock at the end of 2022, when the share price was over $300 After reaping huge profits, Gates criticized COVID-19 jabs, stating they don’t block infection,... read full story
"The Truth About COVID-19,"
